by mg6754@ | Nov 6, 2024 | Genetic Testing, Psychiatric Pharmacogenetics Testing, Psychiatry
Groundbreaking Genetic Clozapine Test Set to Transform Patient Outcomes and Save NHS £1.78 Billion LONDON, UK, 2 October 2024 – Myogenes, a leading innovator in genetic testing, has been awarded a grant from Innovate UK, the UK’s innovation agency, to further...
by mg6754@ | Jul 10, 2024 | Genetic Testing, Pharmacogenomics
National Schizophrenia Awareness Day: Shedding Light on a Misunderstood Condition On July 25th, the UK observes National Schizophrenia Awareness Day, a vital initiative aimed at demystifying one of the most misunderstood and stigmatised mental health conditions. This...
by mg6754@ | May 13, 2024 | Pharmacogenomics
Pharmacogenetics Testing for Mental Health: Tailoring Treatment to Your DNA Mental health disorders, such as depression and anxiety, affect a significant portion of the population and can have a significant impact on quality of life. Unfortunately, finding the right...
by mg6754@ | Jun 26, 2023 | Genetic Testing, Psychiatric Pharmacogenetics Testing, Psychiatry
Understanding Genetic Testing for Mental Health Medications Finding the right medications for mental health issues can be challenging, as each person’s response to treatment can vary significantly. It can be frustrating to experience no improvement or even worsening...
by mg6754@ | Mar 28, 2023 | Hereditary Cancer
Hereditary Cancer Testing: What You Need to Know Cancer is a disease that affects millions of people worldwide, with many cases being hereditary. If your family has a history of cancer, you may be at a higher risk of developing the disease. However, early detection...
Recent Comments